CN114437997B - Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product - Google Patents
Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product Download PDFInfo
- Publication number
- CN114437997B CN114437997B CN202210361077.6A CN202210361077A CN114437997B CN 114437997 B CN114437997 B CN 114437997B CN 202210361077 A CN202210361077 A CN 202210361077A CN 114437997 B CN114437997 B CN 114437997B
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- lactobacillus plantarum
- fermented product
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 68
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 66
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 66
- 239000008280 blood Substances 0.000 title claims abstract description 24
- 210000004369 blood Anatomy 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims description 16
- 238000004321 preservation Methods 0.000 claims abstract description 8
- 238000009629 microbiological culture Methods 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims description 72
- 238000000855 fermentation Methods 0.000 claims description 23
- 230000004151 fermentation Effects 0.000 claims description 23
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000012258 culturing Methods 0.000 claims description 15
- 244000197580 Poria cocos Species 0.000 claims description 13
- 235000008599 Poria cocos Nutrition 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 244000302512 Momordica charantia Species 0.000 claims description 12
- 235000009811 Momordica charantia Nutrition 0.000 claims description 12
- 235000008708 Morus alba Nutrition 0.000 claims description 12
- 240000000249 Morus alba Species 0.000 claims description 12
- 241000756042 Polygonatum Species 0.000 claims description 12
- 238000011081 inoculation Methods 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 238000004659 sterilization and disinfection Methods 0.000 claims description 11
- 244000144730 Amygdalus persica Species 0.000 claims description 10
- 240000002624 Mespilus germanica Species 0.000 claims description 10
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 10
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 10
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 10
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 10
- 244000046146 Pueraria lobata Species 0.000 claims description 10
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 10
- 235000020710 ginseng extract Nutrition 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 9
- 244000099147 Ananas comosus Species 0.000 claims description 8
- 235000007119 Ananas comosus Nutrition 0.000 claims description 8
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 8
- 235000015190 carrot juice Nutrition 0.000 claims description 8
- 239000011268 mixed slurry Substances 0.000 claims description 8
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 7
- 235000019206 astragalus extract Nutrition 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 238000009630 liquid culture Methods 0.000 claims description 7
- 240000004371 Panax ginseng Species 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 5
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 5
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 4
- 235000018365 Momordica dioica Nutrition 0.000 claims description 4
- 239000001888 Peptone Substances 0.000 claims description 4
- 108010080698 Peptones Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 235000012907 honey Nutrition 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 claims description 4
- 235000019319 peptone Nutrition 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 claims description 4
- 239000001393 triammonium citrate Substances 0.000 claims description 4
- 235000011046 triammonium citrate Nutrition 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 229940107666 astragalus root Drugs 0.000 claims description 3
- 210000002421 cell wall Anatomy 0.000 claims description 3
- 229910052564 epsomite Inorganic materials 0.000 claims description 3
- 239000002609 medium Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 2
- 235000015468 Lycium chinense Nutrition 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 229940047169 astragalus root extract Drugs 0.000 claims description 2
- 230000008520 organization Effects 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 21
- 230000002496 gastric effect Effects 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 150000002772 monosaccharides Chemical class 0.000 abstract description 4
- 150000004676 glycans Chemical class 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 3
- 229920001282 polysaccharide Polymers 0.000 abstract description 3
- 239000005017 polysaccharide Substances 0.000 abstract description 3
- 235000019985 fermented beverage Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 30
- 239000000047 product Substances 0.000 description 29
- 230000000694 effects Effects 0.000 description 15
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 11
- 108010028144 alpha-Glucosidases Proteins 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000002054 inoculum Substances 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 229940039696 lactobacillus Drugs 0.000 description 5
- 230000031700 light absorption Effects 0.000 description 5
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013997 pineapple juice Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229960000448 lactic acid Drugs 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- HDXIQHTUNGFJIC-UHFFFAOYSA-N (25R)-spirost-5-en-3beta-ol 3-O-<O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside> Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O HDXIQHTUNGFJIC-UHFFFAOYSA-N 0.000 description 1
- FNMGRVLXWOVONV-UHFFFAOYSA-N 1,3-thiazin-4-one Chemical compound O=C1C=CSC=N1 FNMGRVLXWOVONV-UHFFFAOYSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- VNONINPVFQTJOC-RXEYMUOJSA-N Collettiside III Natural products O([C@@H]1[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@H](C)[C@@]6(O[C@H]5C4)OC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 VNONINPVFQTJOC-RXEYMUOJSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000011362 coarse particle Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VNONINPVFQTJOC-ZGXDEBHDSA-N dioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O VNONINPVFQTJOC-ZGXDEBHDSA-N 0.000 description 1
- CJNUQCDDINHHHD-APRUHSSNSA-N dioscin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O CJNUQCDDINHHHD-APRUHSSNSA-N 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000225 effect on diabetes Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008317 extracellular mechanism Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 108091005995 glycated hemoglobin Proteins 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- VNONINPVFQTJOC-UHFFFAOYSA-N polyphyllin III Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(C)C(O)C(O)C1O VNONINPVFQTJOC-UHFFFAOYSA-N 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010971 suitability test Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Abstract
The invention relates to the technical field of microorganisms, in particular to lactobacillus plantarum SF-L38 and application thereof in preparing a blood sugar control product, wherein lactobacillus plantarum SF-L38 is preserved in China general microbiological culture Collection center (CGMCC) at 23 months 9 and 2021, the preservation address is No. 3 of Beijing Shang Yang West Lu No.1 of the Korean district, the preservation number is CGMCC No.23475, and the lactobacillus plantarum SF-L38 is named as lactobacillus plantarum in classificationLactobacillus plantarum. The lactobacillus plantarum SF-L38 provided by the invention has high adhesion and strong gastrointestinal adaptability, and meanwhile, the lactobacillus plantarum SF-L38 is used as a strain to ferment to prepare a fermented beverage, so that the conversion of polysaccharides into monosaccharides can be inhibited, the blood sugar index can be improved, and the lactobacillus plantarum SF-L38 has important functions of preventing and treating diabetes.
Description
Technical Field
The invention relates to the technical field of microorganisms, and in particular relates to lactobacillus plantarum SF-L38 and application thereof in preparation of a blood sugar control product.
Background
Diabetes mellitus is a common, frequent and life-long-lasting disease caused by an inappropriate elevation of blood glucose (a monosaccharide) levels due to the body's inability to normally release or utilize insulin. In recent years, the prevalence rate of diabetes in China is gradually rising. According to survey data, displaying: "in the population over 20 years old in our country, the prevalence rate of diabetes of men and women respectively reaches 10.6% and 8.8%, and the prevalence rate of diabetes is 9.7%, so that it is calculated that the total prevalence rate of diabetes in the whole country is about 9200 ten thousand people. "the number of diabetes patients in 2019 in China is about 1.16 hundred million, and China has become the country with the most diabetes patients worldwide; at the same time, the number of diabetic patients is still continuously increasing rapidly. The number of people suffering from diabetes in 2040 years in China is predicted to reach 1.51 hundred million people. The growth rate of the insulin market in China also exceeds the average growth rate in the world.
The drug treatment of diabetes is divided into insulin treatment, oral hypoglycemic western medicine treatment and Chinese medicine treatment, and the biotechnology treatment is developed at present. Patent CN201610629475.6 discloses a diabetes treatment product containing an oral fixed-release formulation for fixed-release in the terminal ileum and colon. CN201711432775.6 discloses a synthetic method of a drug for treating diabetes, namely 2- (phenylamino) -4H-benzo [ e ] [1,3] thiazin-4-one. CN201110375880.7 discloses an application of dioscin in preparing a medicament for preventing and treating diabetes. CN201110073133.8 discloses a Xinjiang achillea preparation applied to a medicine for treating diabetes and a preparation method thereof. CN200910114494.5 discloses a method for preparing alpha-glucosidase inhibitor by microbial fermentation for treating diabetes. In conclusion, the western medicines for treating diabetes are high in price and large in toxic and side effects, and can treat symptoms and not root causes; the Chinese patent medicine has slow effect and long time for reducing blood sugar.
Disclosure of Invention
Aiming at the problems of great side effect of western medicines, slow effect of traditional Chinese medicines and the like in the prior art, the invention provides the lactobacillus plantarum SF-L38 and the application thereof in preparing blood sugar control products, which can effectively inhibit polysaccharide in human bodies from being converted into monosaccharide, improve blood sugar indexes and have the effects of preventing and treating diabetes.
In a first aspect, the present invention provides a Lactobacillus plantarum SF-L38, a Lactobacillus plantarum bacterium（Lactobacillus plantarum) The biological culture medium is preserved in the China general microbiological culture Collection center with the preservation number of CGMCC No.23475, the preservation date of 2021, 9 months and 23 days, and the preservation organization address: xilu No.1 Hospital No. 3, Beijing, Chaoyang, North.
In a second aspect, the invention provides a culture method of lactobacillus plantarum SF-L38, which comprises the steps of inoculating lactobacillus plantarum SF-L38 into a sterilized MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to obtain a lactobacillus plantarum SF-L38 culture solution.
Further, the MRS liquid culture medium comprises the following components: 10.0g of peptone, 5.0g of beef powder, 4.0g of yeast powder and K2HPO4·7H2O2.0 g, triammonium citrate 2.0g, glucose 20.0g, CH3COONa·3H2O 5.0g，MgSO4·7H2O 0.2g，MnSO4·4H2O0.05 g, Tween 801.0 mL, agar 15.0g, and distilled water 1000 mL.
In a third aspect, the invention provides an application of lactobacillus plantarum SF-L38, namely, an application of lactobacillus plantarum SF-L38 in preparing a blood sugar control product.
In a fourth aspect, the present invention provides a method for preparing a fermented product using lactobacillus plantarum SF-L38, comprising the steps of:
(1) respectively crushing ginseng, medlar, tuckahoe, kudzu root, astragalus root, mulberry, balsam pear and fragrant solomonseal rhizome, adding water, decocting to obtain extracting solutions, concentrating the extracting solutions, and then carrying out spray drying to respectively obtain ginseng extract, medlar extract, tuckahoe extract, kudzu root extract, astragalus root extract, mulberry extract, balsam pear extract and fragrant solomonseal rhizome extract;
(2) mixing Ginseng radix extract, fructus Lycii extract, Poria extract, radix Puerariae extract, radix astragali extract, Mori fructus extract, fructus Momordicae Charantiae extract, rhizoma Polygonati Odorati extract with rhizoma Dioscoreae powder, Sucus Dauci Sativae and purified water to obtain mixed slurry, autoclaving at 120 deg.C for 30min, and cooling to 40 deg.C to obtain sterilized solution;
(3) inoculating lactobacillus plantarum SF-L38 into a sterilized MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to obtain a lactobacillus plantarum SF-L38 culture solution;
(4) inoculating lactobacillus plantarum SF-L38 culture solution into a sterilization solution, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 20h to obtain fermentation liquor;
(5) breaking cell wall of the fermentation liquid, adding concentrated juice of fructus Persicae and concentrated juice of fructus Ananadis Comosi, mixing, breaking cell wall pressure of 20Mpa, and pasteurizing to obtain fermented product.
Further, the fermentation product comprises the following raw materials in parts by weight: 50-70 parts of purified water, 1-2 parts of a ginseng extract, 2-5 parts of a wolfberry extract, 2-5 parts of a poria cocos extract, 1-3 parts of a pueraria extract, 3-5 parts of a astragalus extract, 1-2 parts of a mulberry extract, 2-6 parts of a bitter gourd extract, 2-3 parts of a polygonatum extract, 2-4 parts of rhizoma dioscoreae powder, 2-7 parts of carrot juice, 4-6 parts of honey peach concentrated juice and 3-5 parts of pineapple concentrated juice.
Further, the fermentation product comprises the following raw materials in parts by weight: 60 parts of purified water, 1 part of ginseng extract, 3 parts of medlar extract, 2 parts of poria cocos extract, 2 parts of kudzu root extract, 3 parts of astragalus extract, 2 parts of mulberry extract, 4 parts of bitter gourd extract, 2 parts of polygonatum extract, 3 parts of Chinese yam powder, 4 parts of carrot juice, 5 parts of honey peach concentrated juice and 4 parts of pineapple concentrated juice.
The invention adopts the following mechanism of medicinal action of each auxiliary material:
ginseng: has effects of invigorating primordial qi, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing. The nature and taste are sweet and slightly bitter.
Rhizoma dioscoreae: tonify spleen and stomach, promote the production of body fluid and benefit lung, tonify kidney and astringe essence, clear heat and remove toxicity.
Medlar: nourish liver, nourish kidney, moisten lung.
Tuckahoe, poria cocos: sweet and bland in flavor and mild in nature. It enters heart, lung, spleen and kidney meridians. Induce diuresis and drain dampness, invigorate spleen and calm heart.
Kudzu root: sweet, pungent and cool. Has the functions of expelling pathogenic factors from muscles, allaying fever, promoting eruption, promoting the production of body fluid, quenching thirst, invigorating yang and relieving diarrhea.
Astragalus root: tonify qi, strengthen superficies, expel toxin, expel pus, induce diuresis, and promote granulation.
And (3) mulberry fruit: sweet in taste and cold in nature, entering heart, liver and kidney meridians, it has the action of nourishing yin and tonifying blood, and can be used for treating yin deficiency, fluid deficiency, insomnia, etc.
Bitter gourd: has the effects of clearing away summer heat, improving eyesight and detoxifying.
Fragrant solomonseal rhizome: to nourish yin, moisten dryness, promote the production of body fluid and quench thirst.
The lactobacillus plantarum SF-L38 has the advantages of high adhesion and strong gastrointestinal adaptability, and meanwhile, the lactobacillus plantarum SF-L38 is used as a strain for fermentation, so that polysaccharide can be inhibited from being converted into monosaccharide, the blood sugar index can be improved, and the important functions of preventing and treating diabetes mellitus are achieved.
Detailed Description
In order to make those skilled in the art better understand the technical solutions in the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be obtained by a person skilled in the art without making any creative effort based on the embodiments in the present invention, shall fall within the protection scope of the present invention.
The MRS liquid medium used in the following examples included the following components:
10g of peptone, 5g of beef powder, 4g of yeast powder and K2HPO4·7H2O2g, triammonium citrate 2g, glucose 20g, CH3COONa·3H2O 5g、MgSO4·7H2O 0.2g、MnSO4·4H2O0.05 g, Tween 801 mL, and distilled water 1000 mL.
The MRS solid plate medium used in the following examples included the following components:
10g of peptone,Beef powder 5g, yeast powder 4g, K2HPO4·7H2O2g, triammonium citrate 2g, glucose 20g, CH3COONa·3H2O5g、MgSO4·7H2O0.2g、MnSO4·4H20.05g of O, 801 mL of Tween, 15.0g of agar and 1000mL of distilled water;
the preparation method of each substance extract of the following examples is as follows: cleaning Ginseng radix, fructus Lycii, Poria, radix Puerariae, radix astragali, Mori fructus, fructus Momordicae Charantiae, and rhizoma Polygonati Odorati, crushing into coarse particles, decocting with 10 times of water for 2 times respectively for 3 hr and 1 hr, mixing the filtrates, standing for 2 hr, filtering to obtain extractive solution, concentrating the extractive solution under vacuum degree of-0.08 Mpa to 1.10 (80 deg.C), spray drying, and pulverizing into 80 mesh fine powder to obtain extract.
The preparation method of the common yam rhizome powder in the following embodiment comprises the following steps: cleaning rhizoma Dioscoreae slice with clear water, blanching in boiling water for 8min, taking out rhizoma Dioscoreae slice, rinsing with clear water to remove mucus, oven drying rhizoma Dioscoreae slice, and grinding into powder by electric grinder to obtain rhizoma Dioscoreae powder.
The preparation method of the carrot juice and the juicy peach condensed juice in the following embodiments comprises the following steps: precooking peeled radix Dauci Sativae dices and juicy peach dices for 5min, pulping, extracting juice from the pulp with horizontal screw machine, concentrating to 40% with dual-effect vacuum evaporator, sterilizing at high temperature, and cooling to obtain radix Dauci Sativae juice and juicy peach concentrated juice.
The following examples are presented to prepare pineapple juice concentrates: squeezing peeled pineapple, filtering, removing crude fiber, impurities, other suspended substances and colloidal particles which are easy to precipitate, degassing pineapple juice, sterilizing, cooling to 50 deg.C, adding sodium benzoate (0.5 g/kg of pineapple juice), and vacuum concentrating to total sugar (calculated as invert sugar) 60% to obtain concentrated pineapple juice.
Example 1
This example is the isolation and characterization of Lactobacillus plantarum SF-L38
1. A bacterium source: the collection time of the yoghourt is 2021 year and 1 month, and the collection place is Xining City in Qinghai province.
2. Isolation of the Strain
Ten times of gradient dilution is carried out on the yoghourt sample, 100 mu L of each gradient is uniformly coated on an MRS solid plate culture medium, and then the yoghourt sample is taken out and placed in an anaerobic tank to be subjected to anaerobic culture at 37 ℃ overnight;
the next day, colonies with different shapes and sizes grow on the plate, a plurality of characteristic colonies of lactobacillus are selected for the second-generation streak purification treatment, the plate is activated for 1 day in an anaerobic way to obtain a culture, and then the strain identification is carried out.
The isolated lactobacillus plantarum SF-L38 of the present invention has the following microbiological characteristics: the bacillus circulans is usually 0.9-1.2 vtm x 3.0-8.0 μm, single, paired or short chain. Usually lacking flagella, but able to move. Gram positive, no sporulation. Facultative anaerobe, with a surface colony diameter of about 3mm, convex, round, smooth, fine, white, occasionally light yellow or dark yellow. Can ferment pentose or gluconate, and the final product contains lactic acid more than 85%. Can produce DL-lactic acid, grow in gluconate, and produce CO2. Fermentation of 1 molecule of ribose or other pentose sugar produces 1 molecule of lactic acid and 1 molecule of acetic acid. Can grow at 15 ℃, and the optimal growth temperature is 30-35 ℃ generally.
3. Identification of Lactobacillus plantarum SF-L38
(1) Identification unit: biometrics (Shanghai) Ltd.
(2) Primer sequences
27F：5'- AGAGTTTGATCMTGGCTCAG -3'；
1492R：5'- GGTTACCTTGTTACGACTT -3'。
(3) Identified sequences
AAGGGTTACCTTGTTACGACTTCACCCTAATCATCTGTCCCACCTTAGGCGGCTGGTTCCTAAAAGGTTACCCCACCGACTTTGGGTGTTACAAACTCTCATGGTGTGACGGGCGGTGTGTACAAGGCCCGGGAACGTATTCACCGCGGCATGCTGATCCGCGATTACTAGCGATTCCGACTTCATGTAGGCGAGTTGCAGCCTACAATCCGAACTGAGAATGGCTTTAAGAGATTAGCTTACTCTCGCGAGTTCGCAACTCGTTGTACCATCCATTGTAGCACGTGTGTAGCCCAGGTCATAAGGGGCATGATGATTTGACGTCATCCCCACCTTCCTCCGGTTTGTCACCGGCAGTCTCACCAGAGTGCCCAACTTAATGCTGGCAACTGATAATAAGGGTTGCGCTCGTTGCGGGACTTAACCCAACATCTCACGACACGAGCTGACGACACCATGCACCACCTGTATCCATGTCCCCGAAGGGAACGTCTAATCTCTTAGATTTGCATAGTATGTCAAGACCTGGTAAGGTTCTTCGCGTAGCTTCGAATTAAACCACATGCTCCACCGCTTGTGCGGGCCCCCGTCAATTCCTTTGAGTTTCAGCCTTGCGGCCGTACTCCCCAGGCGGAATGCTTAATGCGTTAGCTGCAGCACTGAAGGGCGGAAACCCTCCAACACTTAGCATTCATCGTTTACGGTATGGACTACCAGGGTATCTAATCCTGTTTGCTACCCATACTTTCGAGCCTCAGCGTCAGTTACAGACCAGACAGCCGCCTTCGCCACTGGTGTTCTTCCATATATCTACGCATTTCACCGCTACACATGGAGTTCCACTGTCCTCTTCTGCACTCAAGTTTCCCAGTTTCCGATGCACTTCTTCGGTTGAGCCGAAGGCTTTCACATCAGACTTAAAAAACCGCCTGCGCTCGCTTTACGCCCAATAAATCCGGACAACGCTTGCCACCTACGTATTACCGCGGCTGCTGGCACGTAGTTAGCCGTGGCTTTCTGGTTAAATACCGTCAATACCTGAACAGTTACTCTCAGATATGTTCTTCTTTAACAACAGAGTTTTACGAGCCGAAACCCTTCTTCACTCACGCGGCGTTGCTCCATCAGACTTTCGTCCATTGTGGAAGATTCCCTACTGCTGCCTCCCGTAGAGTTTGGGCCGTGTCTCAGTCCCAATGTGGCCGATTACCCTCTCAGTCGGCTACGTATCATTGCCATGGTGAGCCGTTACCCCACCATCTAGCTATACGCCGCGGGACCATCCAAAGTGATAGCCGAAGCCATCTTTCAAGCTCGGACATGCGGTTCCAGTGTATGCGTATAGCATCTGTTCAGTGTATCCCCGCTCTGGCCAGTTTCCCACGTGTTTACTTCAC。
(4) Identification results
This strain was identified as Lactobacillus (Lactobacillus), Lactobacillus plantarum (Lactobacillus plantarum).
Example 2
The preparation method of the lactobacillus plantarum SF-L38 fermented product comprises the following steps:
(1) firstly, 60 parts of purified water, 1 part of ginseng extract, 3 parts of Chinese yam powder, 3 parts of medlar extract, 2 parts of tuckahoe extract, 2 parts of kudzu root extract, 3 parts of astragalus extract, 2 parts of mulberry extract, 4 parts of bitter gourd extract, 2 parts of polygonatum extract and 4 parts of carrot juice are mixed according to a formula ratio to obtain mixed slurry.
(2) Conveying the mixed slurry prepared in the step (1) into a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 40 ℃ to obtain a sterilization solution;
(3) inoculating lactobacillus plantarum SF-L38 into an MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to prepare an inoculant;
(4) inoculating the lactobacillus plantarum SF-L38 inoculant prepared in the step (3) into the sterilized solution prepared in the step (2), wherein the inoculation amount is 1%, and culturing at 37 ℃ for 20h to prepare a fermentation solution;
(5) after the fermentation in the step (4) is finished, conveying the prepared fermentation liquor to a high-pressure spraying wall breaking machine, and setting the pressure to be 20MPa for wall breaking treatment;
(6) and (4) mixing and seasoning the fermentation liquor subjected to the wall breaking in the step (5) with 5 parts of juicy peach concentrated juice and 4 parts of pineapple concentrated juice, and performing pasteurization to obtain a fermented product.
Example 3
The preparation method of the lactobacillus plantarum SF-L38 fermented product comprises the following steps:
(1) firstly, mixing 50 parts of purified water, 2 parts of ginseng extract, 2 parts of Chinese yam powder, 2 parts of medlar extract, 3 parts of poria cocos extract, 1 part of kudzu root extract, 5 parts of astragalus extract, 2 parts of mulberry extract, 2 parts of bitter gourd extract, 3 parts of polygonatum extract and 7 parts of carrot juice according to a formula ratio to obtain mixed slurry;
(2) conveying the mixed slurry prepared in the step (1) into a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 40 ℃ to obtain a sterilization solution;
(3) inoculating lactobacillus plantarum SF-L38 into an MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to prepare an inoculant;
(4) inoculating the lactobacillus plantarum SF-L38 inoculant prepared in the step (3) into the sterilized solution prepared in the step (2), wherein the inoculation amount is 1%, and culturing at 37 ℃ for 20h to prepare a fermentation solution;
(5) after the fermentation in the step (4) is finished, conveying the prepared fermentation liquor to a high-pressure spraying wall breaking machine, and setting the pressure to be 20MPa for wall breaking treatment;
(6) and (3) mixing and seasoning the wall-broken fermentation liquor obtained in the step (5) with 4 parts of juicy peach concentrated juice and 3 parts of pineapple concentrated juice, and performing pasteurization to obtain a fermented product.
Example 4
The preparation method of the lactobacillus plantarum SF-L38 fermented product comprises the following steps:
(1) firstly, mixing 70 parts of purified water, 1 part of ginseng extract, 4 parts of Chinese yam powder, 5 parts of medlar extract, 5 parts of poria cocos extract, 3 parts of kudzu root extract, 4 parts of astragalus extract, 1 part of mulberry extract, 6 parts of bitter gourd extract, 2 parts of polygonatum extract and 2 parts of carrot juice according to a formula ratio to obtain mixed slurry;
(2) conveying the mixed slurry prepared in the step (1) into a sterilization container, performing high-pressure sterilization at 120 ℃ for 30min, and then cooling to 40 ℃ to obtain a sterilization solution;
(3) inoculating lactobacillus plantarum SF-L38 into an MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to prepare an inoculant;
(4) inoculating the lactobacillus plantarum SF-L38 inoculant prepared in the step (3) into the sterilized solution prepared in the step (2), wherein the inoculation amount is 1%, and culturing at 37 ℃ for 20h to prepare a fermentation solution;
(5) after the fermentation in the step (4) is finished, conveying the prepared fermentation liquor to a high-pressure spraying wall breaking machine, and setting the pressure to be 20MPa for wall breaking treatment;
(6) and (3) mixing and seasoning the wall-broken fermentation liquor obtained in the step (5) with 6 parts of juicy peach concentrated juice and 5 parts of pineapple concentrated juice, and performing pasteurization to obtain a fermented product.
Comparative example 1
Comparative example 1 differs from the preparation method of example 2 in that lactobacillus plantarum JYLP-326 was used for fermentation, and lactobacillus plantarum JYLP-325 was purchased from China general microbiological culture Collection center (CGMCC NO. 18038), and the fermented product was prepared.
Comparative example 2
Comparative example 2 the preparation method of example 2 is different, adopt plant lactobacillus JYLP-375 to ferment, plant lactobacillus JYLP-375 is bought from China general microbiological culture Collection center of China Committee for culture Collection of microorganisms, the serial number CGMCC NO.18039, make fermented products.
Example 5 Lactobacillus plantarum SF-L38 adhesion Property testing
This experiment was conducted by testing the ability of Lactobacillus plantarum SF-L38 obtained in example 1 to adhere to extracellular mechanisms.
Inoculating Lactobacillus plantarum SF-L38 to MRS liquid according to the inoculation amount of 1%Culturing at 37 deg.C for 12-14 h in culture medium, centrifuging zymocyte solution at 8000r/min for 15 min, removing supernatant, collecting precipitated thallus, mixing thallus with RPMI-1640 cell culture medium to reach concentration of 108CFU/mL. The prepared bacterial suspension was added to a 24-well plate at 1ml per well, and the 24-well plate was incubated in 5% CO295% CO in air2Culturing at 37 deg.C for 3 hr in incubator, absorbing non-adhesive bacterial suspension, washing with phosphate buffer salt for 5 times, adding phosphate buffer solution containing polyethylene glycol octyl phenyl ether to dissolve cells, and adding sterile water to dissolve. And finally counting, wherein the culture condition is constant-temperature anaerobic culture at 37 ℃, and counting the number of viable bacteria after 2-3 days (GB4789.35 method detection).
The comparative strains were: JYLP-375, JYLP-326 and BB12, wherein BB12 is a standard product of a high-adhesion Bifidobacterium strain recognized in the industry, and the strains are all derived from an open strain depository and can be purchased from the market. As can be seen from Table 1, 0.2% is a relatively ideal index, and the results show that the adhesion of Lactobacillus plantarum SF-L38 of the present invention has a significant advantage.
TABLE 1 Lactobacillus plantarum SF-L38 adhesion characteristics test results
EXAMPLE 6 Lactobacillus plantarum SF-L38 gastrointestinal compliance test
The experiment was carried out using Lactobacillus plantarum SF-L38 obtained in example 1.
(1) Configuration of simulated gastric fluid: pepsin was dissolved in sterile physiological saline (0.9% w/v) and the pH was adjusted to 3.0 to a final concentration of 3 g/L. Filtering with 0.22 μm sterile filter membrane, and mixing;
(2) preparation of simulated intestinal fluid: trypsin was dissolved in sterilized normal saline (0.9% w/v, pH adjusted to 8.0) to a final concentration of 1g/L, and bile salt was added to a final concentration of 0.3%. Filtering with 0.22 μm sterile filter membrane, and mixing;
(3) the experiments were carried out after three successive generations (18 h each) of different L.plantarum (JYLP-375, JYLP-326 and SF-L38) were activated. Measuring the OD value of the continuous activated third-generation strain under A600, and calculating the required amount of the OD 5;
(4) centrifuging the OD 5 bacterial liquid at 8000G for 10min, discarding the supernatant, suspending in 1mL simulated gastric juice, culturing at 37 deg.C for 3h, and counting viable bacteria on the plate;
(5) taking 8000G bacteria liquid treated by simulated gastric juice, centrifuging for 10min, discarding supernatant, suspending in simulated intestinal fluid with the same volume, culturing at 37 ℃ for 4h, and counting viable bacteria on a flat plate.
Survival after tolerating gastrointestinal fluids (%) × (number of viable bacteria in bacterial suspension after tolerating simulated intestinal fluids/number of original viable bacteria in bacterial suspension) x 100%.
TABLE 2 Lactobacillus plantarum SF-L38 gastrointestinal tract suitability test
The result shows that the lactobacillus plantarum SF-L38 has stronger gastrointestinal adaptability than other lactobacillus plantarum.
Example 7 inhibitory Activity on alpha-glucosidase
The activity of the functional product for preventing diabetes on inhibiting alpha-glucosidase is determined: to 150. mu.L of 20mM 4-nitrophenol-. alpha. -D-glucopyranoside (PNPG) solution and 25. mu.L of the sample to be tested (fermented products prepared in example 2, example 3, example 4, comparative example 1 and comparative example 2, respectively) were added 150. mu.L of LPBS, and the mixture was water-bathed at 37 ℃ for 10 min. 50 μ L of alpha-glucosidase solution (0.17U/mL) extracted from rat intestine was added and the reaction was continued for 10 min. 1ml of 0.1MNa was added2CO3As a reaction termination solution. And measuring the light absorption value of the reaction solution at 405nm, wherein the light absorption value is in direct proportion to the free amount of 4-nitrophenol (PNP). In the reaction system, 0.1MPBS with pH of 6.8 is used as a blank control of an alpha-glucosidase solution and a sample to be detected, and the inhibitory activity of the sample is calculated by adopting the following formula:
enzyme inhibition (%) = [1- (C-D)/(A-B) ]. times.100%,
wherein A is the measured absorbance of a solution containing alpha-glucosidase but not containing a sample;
b is a determination light absorption value of a solution without alpha-glucosidase and a sample to be detected;
c is a determination light absorption value of the solution containing the alpha-glucosidase and the sample to be detected;
d is a determination light absorption value which does not contain an alpha-glucosidase solution but contains a sample to be detected;
as can be seen from Table 3, the inhibition ratios of the alpha-glucosidase activities of the lactobacillus plantarum SF-L38 fermented products prepared in examples 2-4 are obviously higher than those of the comparative examples, and the lactobacillus plantarum SF-L38 fermented product prepared in example 2 has the most obvious inhibition effect on the alpha-glucosidase activities, and the inhibition ratio reaches 15.6%, which shows that the lactobacillus plantarum SF-L38 fermented product prepared in the invention can improve the blood glucose index.
TABLE 3 influence of fermentation products prepared in examples and comparative examples on the activity of alpha-glucosidase
Example 8
This example demonstrates the effect of the lactobacillus plantarum SF-L38 fermented product on the prevention and treatment of diabetes.
32 outpatients were treated, 17 males and 15 females at age 35-60 years. This example uses the Lactobacillus plantarum SF-L38 fermented product of example 2, in an amount of 20ml three times a day. 15 days is a course of treatment, and six courses of treatment are taken.
Evaluation criteria:
the effect is shown: fasting plasma glucose and 2 hours post-prandial plasma glucose fall to normal ranges; or the blood glucose level of the fasting blood glucose and the blood glucose level of the 2 hours after meal are reduced by more than 40 percent before treatment; the glycated hemoglobin value drops to normal, or more than 30% before treatment.
Improvement: the blood sugar of the fasting blood sugar and the blood sugar of the 2 hours after meal are reduced by more than 20 percent before treatment, but the blood sugar does not reach the significant effect standard; the value of the glycosylated hemoglobin is reduced by more than 10 percent before treatment, but the value of the glycosylated hemoglobin does not reach the significance standard.
And (4) invalidation: the fasting blood sugar and the blood sugar after 2 hours have no decline, or the decline does not reach the improvement standard; the value of the glycosylated hemoglobin is not reduced or the value of the glycosylated hemoglobin is not reduced to reach the improvement standard.
TABLE 4 Lactobacillus plantarum SF-L38 fermented product clinical treatment efficacy
As can be seen from Table 4, the Lactobacillus plantarum SF-L38 fermented product prepared by the method has a good treatment effect on diabetes.
Although the present invention has been described in detail by way of preferred embodiments, the present invention is not limited thereto. Various equivalent modifications or substitutions can be made on the embodiments of the present invention by those skilled in the art without departing from the spirit and scope of the present invention, and these modifications or substitutions are within the scope of the present invention/any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention.
Sequence listing
<110> Shandong sunflower bioengineering Co., Ltd
<120> Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control products
<160> 3
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1397
<212> DNA
<213> Lactobacillus plantarum (Lactobacillus plantarum)
<400> 1
aagggttacc ttgttacgac ttcaccctaa tcatctgtcc caccttaggc ggctggttcc 60
taaaaggtta ccccaccgac tttgggtgtt acaaactctc atggtgtgac gggcggtgtg 120
tacaaggccc gggaacgtat tcaccgcggc atgctgatcc gcgattacta gcgattccga 180
cttcatgtag gcgagttgca gcctacaatc cgaactgaga atggctttaa gagattagct 240
tactctcgcg agttcgcaac tcgttgtacc atccattgta gcacgtgtgt agcccaggtc 300
ataaggggca tgatgatttg acgtcatccc caccttcctc cggtttgtca ccggcagtct 360
caccagagtg cccaacttaa tgctggcaac tgataataag ggttgcgctc gttgcgggac 420
ttaacccaac atctcacgac acgagctgac gacaccatgc accacctgta tccatgtccc 480
cgaagggaac gtctaatctc ttagatttgc atagtatgtc aagacctggt aaggttcttc 540
gcgtagcttc gaattaaacc acatgctcca ccgcttgtgc gggcccccgt caattccttt 600
gagtttcagc cttgcggccg tactccccag gcggaatgct taatgcgtta gctgcagcac 660
tgaagggcgg aaaccctcca acacttagca ttcatcgttt acggtatgga ctaccagggt 720
atctaatcct gtttgctacc catactttcg agcctcagcg tcagttacag accagacagc 780
cgccttcgcc actggtgttc ttccatatat ctacgcattt caccgctaca catggagttc 840
cactgtcctc ttctgcactc aagtttccca gtttccgatg cacttcttcg gttgagccga 900
aggctttcac atcagactta aaaaaccgcc tgcgctcgct ttacgcccaa taaatccgga 960
caacgcttgc cacctacgta ttaccgcggc tgctggcacg tagttagccg tggctttctg 1020
gttaaatacc gtcaatacct gaacagttac tctcagatat gttcttcttt aacaacagag 1080
ttttacgagc cgaaaccctt cttcactcac gcggcgttgc tccatcagac tttcgtccat 1140
tgtggaagat tccctactgc tgcctcccgt agagtttggg ccgtgtctca gtcccaatgt 1200
ggccgattac cctctcagtc ggctacgtat cattgccatg gtgagccgtt accccaccat 1260
ctagctatac gccgcgggac catccaaagt gatagccgaa gccatctttc aagctcggac 1320
atgcggttcc agtgtatgcg tatagcatct gttcagtgta tccccgctct ggccagtttc 1380
ccacgtgttt acttcac 1397
<210> 2
<211> 20
<212> DNA
<213> Artificial sequence
<400> 2
agagtttgat cmtggctcag 20
<210> 3
<211> 19
<212> DNA
<213> Artificial sequence
<400> 3
ggttaccttg ttacgactt 19
Claims (4)
1. The application of lactobacillus plantarum SF-L38 in preparing a fermented product for assisting in reducing blood sugar is characterized in that the preparation method of the fermented product comprises the following steps:
(1) respectively crushing ginseng, medlar, tuckahoe, kudzu root, astragalus root, mulberry, balsam pear and fragrant solomonseal rhizome, adding water, decocting to obtain extracting solutions, concentrating the extracting solutions, and then carrying out spray drying to respectively obtain ginseng extract, medlar extract, tuckahoe extract, kudzu root extract, astragalus root extract, mulberry extract, balsam pear extract and fragrant solomonseal rhizome extract;
(2) mixing Ginseng radix extract, fructus Lycii extract, Poria extract, radix Puerariae extract, radix astragali extract, Mori fructus extract, fructus Momordicae Charantiae extract, rhizoma Polygonati Odorati extract with rhizoma Dioscoreae powder, Sucus Dauci Sativae and purified water to obtain mixed slurry, autoclaving at 120 deg.C for 30min, and cooling to 40 deg.C to obtain sterilized solution;
(3) inoculating lactobacillus plantarum SF-L38 into a sterilized MRS liquid culture medium, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 18h to obtain a lactobacillus plantarum SF-L38 culture solution;
(4) inoculating lactobacillus plantarum SF-L38 culture solution into a sterilization solution, wherein the inoculation amount is 1%, and culturing at 37 ℃ for 20h to obtain fermentation liquor;
(5) breaking cell wall of the fermentation liquid, mixing with concentrated juice of fructus Persicae and concentrated juice of fructus Ananadis Comosi under 20Mpa, and pasteurizing to obtain fermented product;
the Lactobacillus plantarum (A)Lactobacillus plantarum) SF-L38 is preserved in China general microbiological culture Collection center (CGMCC) with the preservation number of CGMCC No.23475, the preservation date of 2021, 9 and 23 days, and the preservation organization address: xilu No.1 Hospital No. 3, Beijing, Chaoyang, North.
2. The use according to claim 1, wherein the MRS liquid medium comprises the following components: 10.0g of peptone, 5.0g of beef powder, 4.0g of yeast powder and K2HPO4·7H2O2.0 g, triammonium citrate 2.0g, glucose 20.0g, CH3COONa·3H2O 5.0g，MgSO4·7H2O 0.2g，MnSO4·4H2O0.05 g, Tween 801.0 mL, agar 15.0g, and distilled water 1000 mL.
3. The use according to claim 1, wherein the fermented product comprises the following raw materials in parts by weight: 50-70 parts of purified water, 1-2 parts of a ginseng extract, 2-5 parts of a wolfberry extract, 2-5 parts of a poria cocos extract, 1-3 parts of a pueraria extract, 3-5 parts of a astragalus extract, 1-2 parts of a mulberry extract, 2-6 parts of a bitter gourd extract, 2-3 parts of a polygonatum extract, 2-4 parts of rhizoma dioscoreae powder, 2-7 parts of carrot juice, 4-6 parts of honey peach concentrated juice and 3-5 parts of pineapple concentrated juice.
4. The use according to claim 3, wherein the fermented product comprises the following raw materials in parts by weight: 60 parts of purified water, 1 part of ginseng extract, 3 parts of medlar extract, 2 parts of tuckahoe extract, 2 parts of kudzu root extract, 3 parts of astragalus extract, 2 parts of mulberry extract, 4 parts of bitter gourd extract, 2 parts of polygonatum extract, 3 parts of Chinese yam powder, 4 parts of carrot juice, 5 parts of honey peach concentrated juice and 4 parts of pineapple concentrated juice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210361077.6A CN114437997B (en) | 2022-04-07 | 2022-04-07 | Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210361077.6A CN114437997B (en) | 2022-04-07 | 2022-04-07 | Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114437997A CN114437997A (en) | 2022-05-06 |
| CN114437997B true CN114437997B (en) | 2022-06-10 |
Family
ID=81359036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210361077.6A Active CN114437997B (en) | 2022-04-07 | 2022-04-07 | Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114437997B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117085079B (en) * | 2023-10-20 | 2024-02-06 | 妙越缇卡生物医药科技(山东)有限公司 | Lactobacillus plantarum SF-L38 fermented product and preparation method and application thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102586155A (en) * | 2012-03-07 | 2012-07-18 | 江南大学 | Lactobacillus plantarum N13 and use thereof |
| CN105567586A (en) * | 2015-12-21 | 2016-05-11 | 南昌大学 | Lactobacillus plantarum having anti-diabetic function and application thereof |
| CN106399196A (en) * | 2016-11-04 | 2017-02-15 | 北京好实沃生物技术有限公司 | Lactobacillus plantarum HEW-A490 and application thereof |
| CN106834196A (en) * | 2017-04-10 | 2017-06-13 | 吉林省农业科学院 | Lactobacillus plantarum CH126 and its application in function of polysaccharide food is prepared |
| CN110791451A (en) * | 2019-11-25 | 2020-02-14 | 山东中科嘉亿生物工程有限公司 | Lactobacillus plantarum JYLP-326 and application thereof in improving sleep and product |
| CN110964659A (en) * | 2019-08-02 | 2020-04-07 | 四川大学 | Lactobacillus plantarum with blood sugar reducing effect, screening method thereof, application medicament and food |
| CN113462613A (en) * | 2021-08-03 | 2021-10-01 | 浙江大学 | Lactobacillus plantarum ZJUIDS04 capable of reducing blood sugar and application thereof |
| CN113647633A (en) * | 2021-09-17 | 2021-11-16 | 山东向日葵生物工程有限公司 | Lactobacillus plantarum SF-L-28 plant beverage capable of protecting liver and reducing lipid and preparation process thereof |
| CN113957021A (en) * | 2021-12-09 | 2022-01-21 | 扬州大学 | Lactobacillus plantarum grx401 with digestion stress resistance and high intestinal adhesion capacity and application thereof |
-
2022
- 2022-04-07 CN CN202210361077.6A patent/CN114437997B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102586155A (en) * | 2012-03-07 | 2012-07-18 | 江南大学 | Lactobacillus plantarum N13 and use thereof |
| CN105567586A (en) * | 2015-12-21 | 2016-05-11 | 南昌大学 | Lactobacillus plantarum having anti-diabetic function and application thereof |
| CN106399196A (en) * | 2016-11-04 | 2017-02-15 | 北京好实沃生物技术有限公司 | Lactobacillus plantarum HEW-A490 and application thereof |
| CN106834196A (en) * | 2017-04-10 | 2017-06-13 | 吉林省农业科学院 | Lactobacillus plantarum CH126 and its application in function of polysaccharide food is prepared |
| CN110964659A (en) * | 2019-08-02 | 2020-04-07 | 四川大学 | Lactobacillus plantarum with blood sugar reducing effect, screening method thereof, application medicament and food |
| CN110791451A (en) * | 2019-11-25 | 2020-02-14 | 山东中科嘉亿生物工程有限公司 | Lactobacillus plantarum JYLP-326 and application thereof in improving sleep and product |
| CN113462613A (en) * | 2021-08-03 | 2021-10-01 | 浙江大学 | Lactobacillus plantarum ZJUIDS04 capable of reducing blood sugar and application thereof |
| CN113647633A (en) * | 2021-09-17 | 2021-11-16 | 山东向日葵生物工程有限公司 | Lactobacillus plantarum SF-L-28 plant beverage capable of protecting liver and reducing lipid and preparation process thereof |
| CN113957021A (en) * | 2021-12-09 | 2022-01-21 | 扬州大学 | Lactobacillus plantarum grx401 with digestion stress resistance and high intestinal adhesion capacity and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice;Mahalingam Balakumar等;《Eur J Nutr.》;20080228;第57卷(第1期);279-295 * |
| 新型复合型饮料的研制;张天爽等;《山西化工》;20211231;第41卷(第3期);13-16 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114437997A (en) | 2022-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113647633B (en) | Lactobacillus plantarum SF-L-28 plant beverage capable of protecting liver and reducing lipid and preparation process thereof | |
| CN105054040B (en) | A kind of composition of probiotics fermention ginseng and its preparation method and application | |
| CN103478738A (en) | Composite with weight-reducing, body-shaping and weight-controlling functions | |
| CN109182207A (en) | One plant has the lactobacillus acidophilus La-SJLH001 for adjusting the prebiotic function such as blood glucose and cholesterol levels and its application | |
| CN112375713B (en) | Lactobacillus longus SF-B-27 and application thereof | |
| CN112438354A (en) | Plant fermentation liquor and preparation method and application thereof | |
| CN107307253A (en) | A kind of ferment drink and its production technology with effect of relaxing bowel | |
| CN114908020B (en) | Lactobacillus plantarum for resisting helicobacter pylori infection and application of lactobacillus plantarum in edible herbal enzyme product | |
| CN114403320A (en) | Lactobacillus fermentum, fermented beverage with weight-losing function and preparation method of fermented beverage | |
| CN114437997B (en) | Lactobacillus plantarum SF-L38 and application thereof in preparation of blood sugar control product | |
| CN115137069A (en) | Lactobacillus delbrueckii subspecies bulgaricus SF-L-18 fermented product and preparation method and application thereof | |
| CN109439504A (en) | A kind of probiotics compound health vinegar and preparation method thereof | |
| CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
| CN114196603A (en) | Bifidobacterium lactis SF-B21 and application thereof in preparing fermented beverage for increasing bone density | |
| CN114521590A (en) | White kidney bean probiotic lipid-reducing tablet for blocking absorption of sugar and oil and preparation method thereof | |
| CN104273612A (en) | Biological type sugarcane drink | |
| CN117025450A (en) | Lactobacillus paracasei SF-L31 and double-bacterium fermented beverage for improving calcium absorption and preparation method thereof | |
| CN115895966B (en) | Bifidobacterium bifidum BL002 for assisting in relieving gout and application thereof | |
| CN110710675A (en) | Prebiotics polypeptide composite probiotics for treating gastrointestinal disorder and abdominal distension and diarrhea and preparation method thereof | |
| CN106389960A (en) | Probiotic fermented Senzhujianzhong oral liquid and preparation method thereof | |
| CN107670002A (en) | A kind of hypoglycemic composition and its preparation method and application | |
| CN114601906A (en) | Jiulongqing enzyme probiotic oral liquid for treating digestive system diseases and preparation method and application thereof | |
| CN1284848C (en) | Dry red persimmon wine and its brewing method | |
| CN117099892B (en) | Anti-fatigue fermented beverage containing bifidobacterium lactis SF-B21 and preparation process thereof | |
| CN117085086B (en) | Qi and blood tonifying ferment and preparation process and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |